GCF Levels of IL-1Beta, MIP-1 Alfa and G-CSF in Gingivitis and Stage I-II-III-IV Periodontitis Patients
Launched by UŞAK UNIVERSITY · Nov 9, 2020
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Plaque index (PI), gingival index (GI), presence of bleeding on probing (BOP), pocket depth (PD) and clinical attachment level (CAL) were used After clinical evaluation, individuals were divided into 6 groups Healthy control groups, gingivitis groups, Stage I groups, Stage II groups, Stage III groups and Stage IV groups GCF samples were collected after clinical periodontal measurement. GCF was obtained using strips of filter paper Kolmogorov-Smirnov and Shapiro Wilk's tests used
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of periodontal diseases
- • Individuals must have 16 permanent teeth in their mouth
- Exclusion Criteria:
- • Diabetes
- • İmmunological diseases
About Uşak University
Uşak University is a distinguished academic institution dedicated to advancing research and education in various fields, including the health sciences. As a clinical trial sponsor, Uşak University is committed to fostering innovation and contributing to medical knowledge through rigorous scientific investigation. The university collaborates with healthcare professionals and researchers to conduct high-quality clinical trials that aim to improve patient outcomes and enhance therapeutic interventions. With a focus on ethical standards and regulatory compliance, Uşak University strives to ensure the integrity and reliability of its research initiatives, ultimately benefiting the broader community and the advancement of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uşak, , Turkey
Patients applied
Trial Officials
ahu dikilitaş
Principal Investigator
University of Usak
fatih karaaslan
Study Chair
University of Usak
umut yiğit
Study Chair
University of Usak
esra özge aydın
Study Chair
University of Usak
Abdullah seçkin ertuğrul
Study Director
University of Usak
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials